|Day Low/High||139.62 / 141.54|
|52 Wk Low/High||94.59 / 140.25|
Monday was a demonstration of pretty much everything analysts can throw at stocks to get you out while the getting is still good.
Time could run out before Larry Culp can complete his turnaround plan at GE.
GE stock hasn't solved its free cash flow conundrum, and might not for some time, says a key analyst.
One of General Electric's biggest liabilities will be outlined on Thursday.
If we can advance without China then who the heck knows where we can go with it.
Just because the stock is still down substantially from its all-time highs doesn't mean that it is still 'cheap'.
The question for us though becomes is this, or when is, the right time for investors to create some value for themselves?
What we have seen of late from a number of chip producers really might be interpreted as pre-recessionary.
Let's go over the charts and indicators for a good entry point and risk level.
Insiders buy for only one reason -- to make money.
CEO Larry Culp's belt tightening has shares seesawing as earnings miss and the dividend is cut.
Danaher reports its ninth straight earnings beat.
It's time for the central bank to show the same level of concern for their misplaced aggression.
The problems at GE are all about hubris and hurt feelings.
GE's 7% surge on Monday is a welcome surprise for gain-starved shareholders.
GE's remaining obstacles are stopping investors from getting too excited about the buying opportunity amid the CEO shakeup.
Flannery's restructuring plan could be realigned itself.
Analyst and market reaction is very positive on GE's CEO shuffle.
GE shareholders welcome the surge as John Flannery is replaced.
Straying from these names could land you in quicksand as the 4th quarter begins.
The diversified company's charts are giving investors and traders the green light to go long.
Earnings have been strong, and analysts will soon start to concentrate more on actual weakness than shadow-boxing weakness.
Investors love the fintech space, the growth entertainment sector, the cloud and the med tech.